Results

Total Results: 1,851 records

Showing results for "adverse".

181. Genitourinary Syndrome of Menopause (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/genitourinary-syndrome-key-questions.pdf
     January 01, 2021 - postmenopausal women, premonpausal women in hypoestrogenic state, transmen with GSM symptoms Adverse … effects of screening: Safety outcomes, adverse events, misdiagnosis, unnecessary diagnostics … Adverse effects of treatment: Safety outcomes, adverse events, adverse systemic events Potential … (KQ5), post-menopausal bleeding (KQ5), endometrial hyperplasia (KQ5), endometrial thickness (KQ5) Adverse … Systemic adverse events: chronic pain, CVA (stroke); VTE (DVT); death; hot flashes; headache; breast

182. Comments to Effective Heath Care Program Draft Documents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
     March 03, 2010 - events, specifically "serious and/or life threatening adverse events." … The pros and cons of using a registry for reporting adverse events are addressed in the "Adverse Event … Do they mean adverse event? We changed this term to adverse event. … Page 13, paragraph 2: The draft paper uses the term "adverse reactions." … We changed this term to adverse event.

183. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medications_executive.pdf
     September 01, 2009 - one adverse event, elevated serum aspartate transaminase (AST) and/or alanine transaminase (ALT) above … Long-Term Benefits and Serious Adverse Events There are several important limitations in the evidence … Absolute rates of serious adverse events varied between 2 and 4 percent. … Early withdrawal due to adverse events was more likely for the combination of statin plus niacin than … However, three of six trials showed significantly more participants experiencing adverse events with

184. Cer-250-Cannabis-Apps-A-E-Surveillance-Report-2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2.pdf
     January 01, 2022 - Reporting on adverse events was sparse. … , nausea, sedation) and study withdrawal due to adverse events. … Sex differences in medical cannabis-related adverse effects. … Adverse Effects of Recreational and Medical Cannabis. … Adverse effects of medical cannabinoids: a systematic review.

185. Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy for Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/rapid-response-chemotherapy-dental.pdf
     July 01, 2023 - Rapid Response: Efficacy of Dental Services for Reducing Adverse Events in Those Receiving Chemotherapy … for Cancer Rapid Response July 2023 Efficacy of Dental Services for Reducing Adverse … In addition to being a serious adverse event, mucositis also facilitates entry of oral bacteria into … However, it is a serious adverse event occurring in some cancer patients, and early dental evaluation … This Rapid Response has addressed a set of adverse outcomes whose incidence or severity potentially

186. Evidence Summary: Pharmacologic and Nonpharmacologic Therapies in Adult Patients With Exacerbation of COPD (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-221-copd-evidence-summary_0.pdf
     October 01, 2019 - • Antibiotics and corticosteroids are not associated with increase in serious adverse events. … • Vitamin D supplementation may improve quality of life. • Serious adverse events were not found to … Aminophyllines were associated with more gastrointestinal adverse events than placebo. … Few adverse events were reported in studies of nonpharmacologic therapies. … of adverse events with imipenem plus cilastatin compared with meropenem.

187. Intravascular Diagnostic Procedures and Imaging Techniques Versus Angiography Alone in Coronary Artery Stenting: Comparative Effectiveness Review | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/coronary-artery-stenting/research
     February 26, 2013 - FFR confers a lower risk of the composite endpoint of death or myocardial infarction (MI) or of major adverse … those undergoing IVUS- and angiography-guided stent placement had no significant association with major adverse … intermediate coronary lesion confers a lower risk of composite endpoint of death or MI, or of major adverse

188. Developing and Piloting a Tool To Create Dot Plots To Summarize Pooled Data for Multiple Outcomes in Systematic Reviews (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/dot-plots-methods.pdf
     October 01, 2021 - Agency for Healthcare Research and Quality (AHRQ; R13HS027701), focusing on data visualization for adverse … The dot plot also shows the number of adverse events in each group. … events, serious adverse events, nausea, vomiting, constipation, somnolence, dizziness, and pruritus … Dot plot for dichotomous outcomes, statins versus placebo or no statin Abbreviations: AE = adverse … Advantages of visualisations to evaluate and communicate adverse event information in randomised

189. Omega-3 Fatty Acids and Maternal and Child Health: An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/omega-3-maternity_executive.pdf
     October 01, 2016 - – Are adverse events associated with specific sources or doses? … Adverse Events The original report identified 21 RCTs that reported on adverse events with n-3 FA supplementation … Pregnant and breastfeeding women reported no serious adverse events, and adverse events in these groups … Few studies reported adverse events, but among the 20 studies that did report adverse events, 60 percent … that reported serious adverse events (or lack thereof), most did not define “serious adverse event

190. Living Systematic Review on Cannabis and Other Plant-Based Treatments for Chronic Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/cer-250-cannabis-apps-a-e-surveillance-report-2-final.pdf
     March 01, 2022 - Reporting on adverse events was sparse. … , nausea, sedation) and study withdrawal due to adverse events. … Sex differences in medical cannabis-related adverse effects. … Adverse Effects of Recreational and Medical Cannabis. … Adverse effects of medical cannabinoids: a systematic review.

191. Antipsychotics-Children-Surveillance-150120 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-surveillance-150120.pdf
     October 01, 2014 - This includes: • Overall adverse events. • Specific adverse events. … • Persistence and reversibility of adverse events. … This includes: • Overall adverse events. • Specific adverse events. … Adverse Events Twelve studies provided adverse-events data for FGAs versus SGAs. … Key Question 2: Adverse Events Twelve studies provided adverse-events data for FGAs versus SGAs.

192. Antenatal Care | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/get-involved/nominated-topics/antenatal-care
     April 07, 2020 - Questions: What is the relationship between prenatal care for women with uncomplicated pregnancies and adverse … number of prenatal visits for low-risk women in high, middle, and low-income countries does not increase adverse … guidance with the potential to increase efficiency and patient satisfaction in clinical care and decrease adverse

193. Appendixes A-I: (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/pbt-lsr-appendixes.pdf
     April 01, 2022 - events and withdrawals due to adverse events for each included study. … Events and Withdrawals Due to Adverse Eventsa Nurmikko, 2007 Moderate RCT Neuropathic pain- … Sex differences in medical cannabis-related adverse effects. … Adverse Effects of Recreational and Medical Cannabis. … Adverse effects of medical cannabinoids: a systematic review. CMAJ. 2008;178(13):1669-78.

194. Disposition of Comments for Migraine in Adults: Preventive Pharmacologic Treatments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
     April 18, 2013 - effects and adverse effects that lead to treatment discontinuation.” … Pediatric safety trials should examine adverse effects at 12 months or more. … We added tables with dose response association with adverse drug effects in children. … We reviewed all evidence of adverse effects with drugs. … We analyzed specific safety outcome (specific adverse effects or treatment discontinuation due to adverse

195. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - In children with JIA, does the rate and type of adverse eventsf differ between the various DMARDs or … How do the efficacy, effectiveness, safety, and adverse effects of treatment with DMARDs differ among … with DMARDs, we focused primarily on serious infections and the development of cancer when assessing adverse … Other adverse events considered included mortality, hepatitis, bone marrow suppression, nausea or vomiting

196. Cannabis-Annual-Update2-Table-E5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-annual-update2-table-e5.xlsx
     March 13, 2023 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse

197. Cannabis-2022-Update-Surv-Rep-1-App-F-5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-update-surv-rep-1-app-F-5.xlsx
     January 01, 2022 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse

198. Cannabis-2022-Surv-Rep-3-Table-F5 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-3-table-F5.xlsx
     January 01, 2022 - Outcomes Quality of Life Outcomes Anxiety and Depression Outcomes Sleep Outcomes Opioid Use Outcomes Adverse … C % (n/N) Any adverse event 3 months: 35% (19/49) vs. 47% (30/52) vs. NR, RR for A vs. … B 0.72 (95% CI 0.49 to 1.07) Serious adverse events: none in any group Withdrawals due to adverse events … B Total patients reporting treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 … adverse events: 13% (28/215) vs. 19.4% (42/216), RR 0.67 (95% CI 0.43 to 1.04) Withdrawals due to adverse

199. Comparative Effectiveness of Therapies for Children With Autism Spectrum Disorder | Effective Health Care (EHC) Program
     effectivehealthcare.ahrq.gov/products/autism-update/clinician
     September 23, 2014 - [evidence high] The evidence is insufficient to understand the adverse events from all other medical … Other Interventions The evidence is insufficient to understand the effectiveness, benefits, or adverse … evidence insufficient] The evidence is insufficient to understand the effectiveness, benefits, or adverse … and aripiprazole, there was not enough evidence to estimate the severity and frequency of potential adverse … which no research has been conducted and on atypical antipsychotics that may be less associated with adverse

200. Autism-Update Clinician (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_clinician.pdf
     September 01, 2014 - .  � The evidence is insufficient to understand the adverse events from all other medical interventions … Other Interventions � The evidence is insufficient to understand the effectiveness, benefits, or adverse … educational intervention.  � The evidence is insufficient to understand the effectiveness, benefits, or adverse … and aripiprazole, there was not enough evidence to estimate the severity and frequency of potential adverse … which no research has been conducted and on atypical antipsychotics that may be less associated with adverse